Self Titration With Apidra to Reach Target Study (START)
NCT01013571
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
493
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG:
insulin glargine
DRUG:
Apidra (insulin glulisine)
Sponsor
Sanofi